BGH Capital and backers including Australian Super have made a second attempt to buy Healthscope, offering the same amount in cash they did when they made a play for the company earlier this year.
The bid values the company at $2.36 per share, or around $4.10 billion.
The price is a 32 per cent premium to Healthscope’s last closing share price - a higher premium to when the suitors bid for the company several months ago.
It is understood Ellerston Capital, which controls about 10 per cent of the company, supports Healthscope’s board offering the BGH consortium due diligence, sources said.
BGH Capital and its backers are understood to be re-bidding for Healthscope after being approached by shareholders urging the consortium to embark on the move.
It comes as Healthscope - the country’s second largest private hospital operator - has a sale underway for a 49 per cent stake in its property portfolio through investment bank UBS.
Light and Wonder rivals out of the Grover game
Light and Wonder is believed to have fended off competition for Grover Gaming from groups including the Australian-listed Aristocrat Leisure and Churchill Downs Incorporated.
Lactalis taps Rothschild for Fonterra asset sale
About 30 parties are so far interested in Fonterra’s valuable portfolio of dairy brands that it has placed up for sale.